Program
4th Swiss RNA Therapeutics Summit
Thursday, 28 January 2027 · University of Bern
Preliminary program · Schedule and program details are subject to change.
More speakers will be announced soon.
Registration, coffee and poster mounting
Welcome desk opens.
Session 1 · Opening keynote and emerging translation projects
Opening remarks
Daniel Blessing · HAYA Therapeutics
“Targeting the Regulatory Genome -Paradigms for lncRNA-Directed Antisense Therapeutics”
Magdalini Polymenidou · University of Zurich
Talk title to be announced
Coffee break and poster session
Coffee, networking and poster viewing.
Session 2 · Short talks
Roxanne van Heurck · Geneva University Hospitals (HUG)
“Working towards the implementation of antisense oligonucleotide therapies for patients with severe neurodevelopmental diseases and ultra-rare molecular diagnoses in Switzerland”
Julia Djonova · University of Zurich
Talk title to be announced
Lunch, poster session and networking
Networking lunch and poster discussions.
Session 3 · Emerging translation projects in academia
- 13:50Sebastian Sjöström · ETH Zurich
“Antisense Oligonucleotides for Autosomal Dominant Tubulointerstitial Kidney Disease” - 14:05Sean Froesne · Kinderspital Zürich
“ASOs targeting a novel inherited metabolic disorder caused by epigenetic silencing” - 14:20Laura Teodori · ETH Zurich
“Accelerating N-of-1 therapy: a cell-free high-throughput antisense oligonucleotide screening”
Session 4 · Translation projects: progress reports
- 14:50Felix Baier · CALDRE Ltd.
“Targeting the Biliary Barrier: A Unique Therapeutic Approach to Cholestatic Liver Disease” - 15:00Tom Edwardson · Procavea
“Expanding siRNA therapies to new tissues with nonviral protein cages” - 15:10Arka Banerjee · 80SBio GmbH
Talk title to be announced
Christian Berk · E. Blum & Co. AG
“Patent Essentials for RNA TX start-ups”
Coffee break and poster session
Coffee, networking and poster viewing.
Session 5 · Industry presentations and closing keynote
- 16:20Soham Mandal · Axolabs
Talk title to be announced - 16:35Felix Gnerlich · RiboCure
"From Liver Delivery to De-Livery: New Tissues with RNAi Drugs”
Gerald Schwank · University of Zurich
“In vivo gene engineering: from monogenic liver diseases to CAR-T cell therapies”
Concluding remarks followed by apéro
Closing of the scientific programme and informal networking.
4th Swiss RNA Therapeutics Summit
Thursday, 28 January 2027 · University of Bern
Preliminary programme · Times and programme details are subject to change.
Registration, coffee and poster mounting
Welcome desk opens.
Session 1 · Opening keynote and industry
Opening remarks
Speaker details to be announced.
Update
Daniel Blessing · Haya Therapeutics
Industry perspectives
- 10:00Roche · Details to be announced
- 10:15Bachem · Details to be announced
- 10:30Cytiva · Details to be announced
Coffee break and poster session
Coffee, networking and poster viewing.
Session 2 · Short talks
HUG, Esperare and nLorem
Roxanne von Heurck · HUG, Geneva
Update
Julia Djonova · Swissmedic
Lunch, poster session and networking
Networking lunch and poster discussions.
Session 3 · Emerging translation projects in academia
Rare kidney disease
Sebastian Sjöström · ETH Zurich
Details to be announced
Sean Froesne · University Children’s Hospital Zurich
Obesity?
Ramesh Pillai · University of Geneva
High-throughput screening for N-of-1 projects
Laura Teodori · ETH Zurich
Session 4 · Translation projects: progress reports
Academic and biotechnology updates
- 14:50Felix Baier · CALDRE
- 15:00Tom Edwardson · Precavea
- 15:10Arka Banerjee · 80S Bio GmbH
How to navigate the IP arena when starting out
Christian Berk · Blum
Coffee break and poster session
Coffee, networking and poster viewing.
Session 5 · Industry and closing keynote
Manufacturing, analytics and GMP
- 16:05Hartmut Jahns · Novartis · Manufacturing and analytics
- 16:20Axolabs · Berlin GMP
- 16:35Company and speaker to be announced
Details to be announced
Gerald Schwank · University of Michigan
Concluding remarks followed by apéro
Closing of the scientific programme and informal networking.
Let’s keep the conversation going.
Have a question about the Summit, registration or sponsorship? Get in touch with the RNATX team or follow us for the latest program announcements.